Susquehanna International Group
BHVN

Susquehanna International Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Susquehanna International Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-201,500
Closed -$30.5M – 14734
2022
Q3 		$30.5M Sell
201,500
-12,500
-6% -$1.85M 0.01% 1102
2022
Q2 		$31.2M Sell
214,000
-64,600
-23% -$8.25M 0.01% 1128
2022
Q1 		$33M Buy
278,600
+122,300
+78% +$15.3M 0.01% 1276
2021
Q4 		$21.5M Sell
156,300
-102,000
-39% -$13M ﹤0.01% 1776
2021
Q3 		$35.9M Sell
258,300
-183,700
-42% -$22.9M ﹤0.01% 1418
2021
Q2 		$42.9M Buy
442,000
+255,100
+136% +$20.7M 0.01% 1310
2021
Q1 		$12.8M Sell
186,900
-211,800
-53% -$17.1M ﹤0.01% 2418
2020
Q4 		$34.2M Sell
398,700
-210,200
-35% -$17.8M 0.01% 1264
2020
Q3 		$39.6M Sell
608,900
-10,900
-2% -$714K 0.01% 997
2020
Q2 		$45.3M Buy
619,800
+85,800
+16% +$4.57M 0.01% 891
2020
Q1 		$18.2M Buy
534,000
+107,700
+25% +$4.92M 0.01% 1239
2019
Q4 		$23.2M Sell
426,300
-136,500
-24% -$6.76M 0.01% 1283
2019
Q3 		$23.5M Sell
562,800
-169,900
-23% -$7.18M 0.01% 1219
2019
Q2 		$32.1M Buy
732,700
+467,900
+177% +$26.4M 0.01% 968
2019
Q1 		$13.6M Buy
264,800
+227,900
+618% +$9.85M 0.01% 1487
2018
Q4 		$1.36M Sell
36,900
-169,600
-82% -$6.11M ﹤0.01% 4141
2018
Q3 		$7.75M Buy
206,500
+23,100
+13% +$850K ﹤0.01% 2180
2018
Q2 		$7.25M Sell
183,400
-156,900
-46% -$4.98M ﹤0.01% 2292
2018
Q1 		$8.77M Buy
340,300
+290,200
+579% +$8.68M ﹤0.01% 1909
2017
Q4 		$1.35M Buy
+50,100
New +$1.38M ﹤0.01% 4638

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Susquehanna International Group's BHVN Position: Q4 2022 in Review

Susquehanna International Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 36,591 shares — an estimated $5.53M sold.

Susquehanna International Group first reported a position in BHVN in Q3 2017 and held it in 20 quarters. The position peaked at $27.2M in Q4 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Susquehanna International Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Susquehanna International Group sold 36,591 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $5.53M.
  • Susquehanna International Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 20 quarters.
  • Susquehanna International Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $27.2M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.